JOINT FILING AGREEMENTJoint Filing Agreement • July 2nd, 2008 • Kirk Randal J • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons names below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Halozyme Therapeutics, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 1st day of July, 2008.
PURCHASE AGREEMENTPurchase Agreement • July 2nd, 2008 • Kirk Randal J • Biological products, (no disgnostic substances) • Virginia
WHEREAS, the Seller is willing to sell to the Buyer, and the Buyer is willing to purchase from the Seller, __________________ (_________) shares of Common Stock (the “Shares”) and a warrant entitling the Seller or its assigns to purchase ________________ (_________) shares (“Warrant” and together with the Shares, “Securities”) of Halozyme Therapeutics, Inc., a Delaware corporation (the “Company”), currently held by the Seller.
